Abstract
Loss of tumor suppression by the p53 protein involves altered or abrogated transcriptional activity resulting in a failure to mediate wild-type cellular responses including cell cycle arrest, senescence, and apoptosis. Timofeev et al (2019) make the fascinating finding that a novel p53 cooperativity mutation devoid of DNA binding results in no tumor suppression but surprising retention of an apoptotic response to chemotherapy and other treatments. This shows a need for rethinking how mutant p53-driven tumors are treated in the clinic.
Original language | English |
---|---|
Pages (from-to) | e103322 |
Journal | EMBO Journal |
Volume | 38 |
Issue number | 20 |
DOIs |
|
State | Published - 15 Oct 2019 |